| Year |
Citation |
Score |
| 2024 |
Fukuda J, Kosuge S, Satoh Y, Sekiya S, Yamamura R, Ooshio T, Hirata T, Sato R, Hatanaka KC, Mitsuhashi T, Nakamura T, Matsuno Y, Hatanaka Y, Hirano S, Sonoshita M. Concurrent targeting of GSK3 and MEK as a therapeutic strategy to treat pancreatic ductal adenocarcinoma. Cancer Science. PMID 38320747 DOI: 10.1111/cas.16100 |
0.39 |
|
| 2023 |
Sekiya S, Fukuda J, Yamamura R, Ooshio T, Satoh Y, Kosuge S, Sato R, Hatanaka KC, Hatanaka Y, Mitsuhashi T, Nakamura T, Matsuno Y, Hirano S, Sonoshita M. Drosophila Screening Identifies Dual Inhibition of MEK and AURKB as an Effective Therapy for Pancreatic Ductal Adenocarcinoma. Cancer Research. OF1-OF12. PMID 37378549 DOI: 10.1158/0008-5472.CAN-22-3762 |
0.399 |
|
| 2022 |
Jiang H, Kimura T, Hai H, Yamamura R, Sonoshita M. as a toolkit to tackle cancer and its metabolism. Frontiers in Oncology. 12: 982751. PMID 36091180 DOI: 10.3389/fonc.2022.982751 |
0.321 |
|
| 2020 |
Yamamura R, Ooshio T, Sonoshita M. Tiny Drosophila makes giant strides in cancer research. Cancer Science. PMID 33275812 DOI: 10.1111/cas.14747 |
0.357 |
|
| 2019 |
Ung PMU, Sonoshita M, Scopton AP, Dar AC, Cagan RL, Schlessinger A. Integrated computational and Drosophila cancer model platform captures previously unappreciated chemicals perturbing a kinase network. Plos Computational Biology. 15: e1006878. PMID 31026276 DOI: 10.1371/Journal.Pcbi.1006878 |
0.542 |
|
| 2018 |
Aoyama N, Miyoshi H, Miyachi H, Sonoshita M, Okabe M, Taketo MM. Transgenic mice that accept Luciferase- or GFP-expressing syngeneic tumor cells at high efficiencies. Genes to Cells : Devoted to Molecular & Cellular Mechanisms. 23: 580-589. PMID 29749672 DOI: 10.1111/Gtc.12592 |
0.359 |
|
| 2018 |
Sonoshita M, Scopton AP, Ung PMU, Murray MA, Silber L, Maldonado AY, Real A, Schlessinger A, Cagan RL, Dar AC. A whole-animal platform to advance a clinical kinase inhibitor into new disease space. Nature Chemical Biology. PMID 29355849 DOI: 10.1038/Nchembio.2556 |
0.513 |
|
| 2017 |
Okada Y, Sonoshita M, Kakizaki F, Aoyama N, Itatani Y, Uegaki M, Sakamoto H, Kobayashi T, Inoue T, Kamba T, Suzuki A, Ogawa O, Taketo MM. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer. Cancer Science. PMID 28178391 DOI: 10.1111/Cas.13187 |
0.405 |
|
| 2017 |
Sonoshita M, Cagan RL. Modeling Human Cancers in Drosophila. Current Topics in Developmental Biology. 121: 287-309. PMID 28057303 DOI: 10.1016/Bs.Ctdb.2016.07.008 |
0.548 |
|
| 2016 |
Kakizaki F, Sonoshita M, Miyoshi H, Itatani Y, Ito S, Kawada K, Sakai Y, Taketo MM. Expression of metastasis suppressor gene AES driven by a YY element in a CpG island promoter and transcription factor YY2. Cancer Science. PMID 27561171 DOI: 10.1111/Cas.13063 |
0.354 |
|
| 2016 |
Sonoshita M, Itatani Y, Kakizaki F, Sakai Y, MMT. Abstract B65: Promotion of colorectal cancer invasion and metastasis through activation of Notch–Dab1–Abl–RhoGEF protein trio Cancer Research. 76. DOI: 10.1158/1538-7445.Tummet15-B65 |
0.496 |
|
| 2015 |
Itatani Y, Sonoshita M, Kakizaki F, Okawa K, Stifani S, Itoh H, Sakai Y, Taketo MM. Characterization of Aes nuclear foci in colorectal cancer cells. Journal of Biochemistry. PMID 26229111 DOI: 10.1093/Jb/Mvv077 |
0.393 |
|
| 2015 |
Sonoshita M, Itatani Y, Kakizaki F, Sakimura K, Terashima T, Katsuyama Y, Sakai Y, Taketo MM. Promotion of colorectal cancer invasion and metastasis through activation of NOTCH-DAB1-ABL-RHOGEF protein TRIO. Cancer Discovery. 5: 198-211. PMID 25432929 DOI: 10.1158/2159-8290.Cd-14-0595 |
0.504 |
|
| 2011 |
Kawada K, Hasegawa S, Murakami T, Itatani Y, Hosogi H, Sonoshita M, Kitamura T, Fujishita T, Iwamoto M, Matsumoto T, Matsusue R, Hida K, Akiyama G, Okoshi K, Yamada M, et al. Molecular mechanisms of liver metastasis. International Journal of Clinical Oncology. 16: 464-72. PMID 21847533 DOI: 10.1007/S10147-011-0307-2 |
0.456 |
|
| 2011 |
Sonoshita M, Aoki M, Fuwa H, Aoki K, Hosogi H, Sakai Y, Hashida H, Takabayashi A, Sasaki M, Robine S, Itoh K, Yoshioka K, Kakizaki F, Kitamura T, Oshima M, et al. Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling. Cancer Cell. 19: 125-37. PMID 21251616 DOI: 10.1016/J.Ccr.2010.11.008 |
0.437 |
|
| 2007 |
Kawada K, Hosogi H, Sonoshita M, Sakashita H, Manabe T, Shimahara Y, Sakai Y, Takabayashi A, Oshima M, Taketo MM. Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes. Oncogene. 26: 4679-88. PMID 17297455 DOI: 10.1038/Sj.Onc.1210267 |
0.37 |
|
| 2004 |
Fujishita T, Doi Y, Sonoshita M, Hiai H, Oshima M, Huebner K, Croce CM, Taketo MM. Development of spontaneous tumours and intestinal lesions in Fhit gene knockout mice British Journal of Cancer. 91: 1571-1574. PMID 15467769 DOI: 10.1038/Sj.Bjc.6602182 |
0.317 |
|
| 2004 |
Kawada K, Sonoshita M, Sakashita H, Takabayashi A, Yamaoka Y, Manabe T, Inaba K, Minato N, Oshima M, Taketo MM. Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes. Cancer Research. 64: 4010-7. PMID 15173015 DOI: 10.1158/0008-5472.Can-03-1757 |
0.357 |
|
| Show low-probability matches. |